ELI LILLY & Co is 2.7x more valuable than AbbVie Inc. by market capitalization ($1.072 T vs $399.47 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | LLY | ABBV |
|---|---|---|
| Market cap | $1.072 T | $399.47 B |
| US-listed rank | #10 | #28 |
| Revenue (latest FY) | $65.18B | $61.16B |
| Net income (latest FY) | $20.64B | $4.23B |
| Net margin | 31.7% | 6.9% |
| P/E (trailing FY) | 51.9 | 94.5 |
| SEC filings | 989 | 1,008 |
ELI LILLY & Co is 2.7x more valuable than AbbVie Inc. by market capitalization ($1.072 T vs $399.47 B).
In their latest fiscal years, ELI LILLY & Co reported $65.18B in revenue while AbbVie Inc. reported $61.16B.
Full pages: ELI LILLY & Co and AbbVie Inc., or browse the full rankings.